Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-12

FDA Approved: POMALIDOMIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for pomalidomide, authorizing the generic pomalidomide to be marketed. This represents a supplemental approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomalidomide (Pomalidomide)

Snippet

SUPPL AP for POMALIDOMIDE (POMALIDOMIDE)